Temporal Characteristics of Adverse Events of Tivozanib vs Sorafenib in Patients With Previously Treated mRCC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles: